Hermas Biotech Private Limited, a active private limited company, was established on 22 October 2014 in Bhiwandi, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74120MH2014PTC258834. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.30 M and a paid-up capital of ₹0.30 M.
It upholds a compliant status. Its leadership includes Mushir Ahmad Sagir Ahmad Shaikh (Director), Naim Ahmad Ishtiaque Ahmad Azmi (Director), Mohammed Qaiser Mohammed Ashhad (Director). Past directors included Adeeb Shaikh Ahmad. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Gala No 1, House No 97, Bandar Mohalla, Thane, Bhiwandi, Bhiwandi, Maharashtra, 421308.
U74120MH2014PTC258834
258834
22 October 2014
₹0.30 M
₹0.30 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Hermas Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mushir Ahmad Sagir Ahmad Shaikh | Director | 22 Oct 2014 | Current |
| Naim Ahmad Ishtiaque Ahmad Azmi | Director | 22 Oct 2014 | Current |
| Mohammed Qaiser Mohammed Ashhad | Director | 14 Mar 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Feb 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hermas Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 51.36% increase. The company also saw a slight decrease in profitability, with a 7.94% decrease in profit. The company's net worth Soared by an impressive increase of 10.48%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Hermas Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Hermas Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hermas Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hermas Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Hermas Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Hermas Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Mohammed Qaiser Mohammed Ashhad was appointed as a Director was appointed as a Director on 14 Mar 2016 & has been associated with this company since 9 years 8 months . was documented.
Mushir Ahmad Sagir Ahmad Shaikh was appointed as a Director was appointed as a Director on 22 Oct 2014 & has been associated with this company since 11 years 1 month . was recorded as a recent event.
Naim Ahmad Ishtiaque Ahmad Azmi was appointed as a Director was appointed as a Director on 22 Oct 2014 & has been associated with this company since 11 years 1 month . was recorded as a recent event.
Hermas Biotech Private Limited was registered on 22 Oct 2014 with Roc Mumbai & aged 11 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Hermas Biotech Private Limited is U74120MH2014PTC258834.
Hermas Biotech Private Limited is headquartered at Gala No 1, House No 97, Bandar Mohalla, Thane, Bhiwandi, Bhiwandi, Maharashtra, 421308.
Hermas Biotech Private Limited was incorporated on 22 October 2014.
The current directors of Hermas Biotech Private Limited are
The primary industry of Hermas Biotech Private Limited is Trade.
Hermas Biotech Private Limited is unlisted.
The authorized capital of Hermas Biotech Private Limited is ₹0.30 M, and the paid-up capital is ₹0.30 M.
The compliance status of Hermas Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX